Denator AB Expands and Strengthens Commercial Operations
News Mar 08, 2010
Denator AB announced that the company has expanded and strengthened its Commercial operations group in Europe through the appointment of Patrik Bjoorn as Application Specialist with the responsibility for Technical Support.
Patrik joins Denator from Biolin Scientific where he worked as Senior Sales and Application specialist with the responsibility of, amongst other things, education of sales and application personnel especially at the 15+ distribution partners of Biolin Scientific. Prior to that, Patrik worked for several years at Q-Sense with establishing a novel Swedish research technology on the global market. He held positions as Sales Director and President of the company’s US branch.
Patrik Bjoorn says: "Denator’s product portfolio is in a very exciting stage of evolution and it is great to become part of the team at such an active time.”
Olof Skold, CEO at Denator, states: “We are delighted to be able to strengthen our Commercial operations group with such a highly experienced individual as Patrik, who has proven his abilities in several successful ventures within the biotech industry. Our products are becoming increasingly well-established in the proteomics market hence our decision to increase our personnel to ensure that we continue to provide high quality customer assistance.”
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Synthetic Biology Breakthrough Means Bacteria Could Produce Our Essential DrugsNews
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles.READ MORE